Developing personalized treatments for glioblastoma using single-cell analysis
A multimodal single-cell approach to developing personalized combinatorial treatments for glioblastoma
This study is looking at glioblastoma, a tough type of brain cancer, to find out how different tumor cells react to different drug combinations, with the goal of discovering the best treatments for each person's unique tumor.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11013886 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma, a complex brain cancer characterized by diverse tumor cell types. By utilizing advanced techniques like single-cell RNA sequencing and flow sorting, the study aims to isolate different tumor cell populations and assess their responses to various drug combinations. This personalized approach seeks to identify the most effective treatments tailored to the unique characteristics of each patient's tumor, potentially improving outcomes for those affected by this aggressive cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with glioblastoma who are seeking innovative treatment options.
Not a fit: Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatment options for patients with glioblastoma.
How similar studies have performed: Previous research has shown promise in using single-cell analysis for cancer treatment, indicating that this approach could lead to significant advancements in personalized medicine.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Petti, Allegra Adele — Massachusetts General Hospital
- Study coordinator: Petti, Allegra Adele
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.